1-20 of 107
Anna Azvolinsky, PhD
Close
Sort by
News

Systematic Review Identifies Sensitive Rapid Point-of-Care ADAMTS13 Assay to Reliably Diagnose TTP

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
June 2025
View News titled, Systematic Review Identifies Sensitive Rapid Point-of-Care ADAMTS13 Assay to Reliably Diagnose TTP
News

Oral Thrombopoietin Receptor Agonist Eltrombopag Also Functions as Iron Chelator, Study Finds

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
June 2025
View News titled, Oral Thrombopoietin Receptor Agonist Eltrombopag Also Functions as Iron Chelator, Study Finds
News

Large Database Study Maps Treatment Use Among Elderly, Veteran Patients With DLBCL

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
June 2025
View News titled, Large Database Study Maps Treatment Use Among Elderly, Veteran Patients With DLBCL
News

Five-Year Results of SEQUOIA Trial Show Maintenance of Benefit for Patients With Del(17p) Treatment-Naïve CLL Treated With Zanubrutinib

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
July 2025
View News titled, Five-Year Results of SEQUOIA Trial Show Maintenance of Benefit for Patients With Del(17p) Treatment-Naïve CLL Treated With Zanubrutinib
News

Results Detail Comparison of Patients With R/R CLL/SLL in Liso-Cel TRANSCEND CLL 004 Trial With Real-World Cohort

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
July 2025
View News titled, Results Detail Comparison of Patients With R/R CLL/SLL in Liso-Cel TRANSCEND CLL 004 Trial With Real-World Cohort
News

MRD Negativity Associated with PFS and OS Benefit in DREAMM-8 Multiple Myeloma Trial

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
July 2025
View News titled, MRD Negativity Associated with PFS and OS Benefit in DREAMM-8 Multiple Myeloma Trial
News

Large Study Clarifies Risk of Thrombosis Associated With Protein S Deficiency

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
June 2025
View News titled, Large Study Clarifies Risk of Thrombosis Associated With Protein S Deficiency
News

Venetoclax Plus Decitabine Shows Similar Efficacy to Intensive Chemotherapy as Front- Line Therapy for Young, Fit Patients With AML

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
May 2025
View News titled, Venetoclax Plus Decitabine Shows Similar Efficacy to Intensive Chemotherapy as Front- Line Therapy for Young, Fit Patients With AML
News

Responses to BCMA CAR T Cells Not Durable in Patients with MM with CNS Involvement

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
April 2025
View News titled, Responses to BCMA CAR T Cells Not Durable in Patients with MM with CNS Involvement
News

Non-Transplant Salvage Therapy Safe for Pediatric, Adolescent Patients with R/R cHL

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
April 2025
View News titled, Non-Transplant Salvage Therapy Safe for Pediatric, Adolescent Patients with R/R cHL
News

Study Maps Clinical Evolution of Fanconi Anemia Using Large Patient Registry

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
March 2025
View News titled, Study Maps Clinical Evolution of Fanconi Anemia Using Large Patient Registry
News

Mass Spectrometry an Effective Method to Detect Measurable Residual Disease in Multiple Myeloma

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
March 2025
View News titled, Mass Spectrometry an Effective Method to Detect Measurable Residual Disease in Multiple Myeloma
News

Combination of Venetoclax, Lower Intensity CPX-351 Shows Positive Results in Early-Stage AML Study

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
February 2025
View News titled, Combination of Venetoclax, Lower Intensity CPX-351 Shows Positive Results in Early-Stage AML Study
News

ASH Publishes Guide to Boosting Accessibility, Diversity in Clinical Trials

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
February 2025
View News titled, ASH Publishes Guide to Boosting Accessibility, Diversity in Clinical Trials
News

Isatuximab Can Be Given as a Shorter Intravenous Infusion to Patients With Multiple Myeloma, New Trial Shows

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
February 2025
View News titled, Isatuximab Can Be Given as a Shorter Intravenous Infusion to Patients With Multiple Myeloma, New Trial Shows
News

Daratumumab Plus Lenalidomide Combination Improves Conversion to MRD-Negative Status in Post-Transplant Patients With Multiple Myeloma

Free
Anna Azvolinsky, PhD
Published: 2024
Abstract
January 2025
View News titled, Daratumumab Plus Lenalidomide Combination Improves Conversion to MRD-Negative Status in Post-Transplant Patients With Multiple Myeloma
News

Discontinuing Maintenance Therapy for Multiple Myeloma Is Feasible, New Study Shows

Free
Anna Azvolinsky, PhD
Published: 2024
Abstract
December 2024
View News titled, Discontinuing Maintenance Therapy for Multiple Myeloma Is Feasible, New Study Shows
News

ASH Recruitment Program Boosts Representation in Hematology Field, Study Shows

Free
Anna Azvolinsky, PhD
Published: 2024
Abstract
December 2024
View News titled, ASH Recruitment Program Boosts Representation in Hematology Field, Study Shows
News

Bispecific T-Cell Engager Results in CR, Clears MRD in Patients with R/R Follicular Lymphoma

Free
Anna Azvolinsky, PhD
Published: 2024
Abstract
January 2025
View News titled, Bispecific T-Cell Engager Results in CR, Clears MRD in Patients with R/R Follicular Lymphoma
News

Quadruple Combination with Brentuximab Vedotin, Nivolumab Continues to Show Strong Efficacy in Early-Stage cHL

Free
Anna Azvolinsky, PhD
Published: 2024
Abstract
January 2025
View News titled, Quadruple Combination with Brentuximab Vedotin, Nivolumab Continues to Show Strong Efficacy in Early-Stage cHL